Lily Aleksandrova, MSc, PhD

Looking to maintain a healthy balance of enthusiasm and critical thinking around the emerging therapeutic potential of psychedelics from bench-to-bedside-to-community, Lily takes every opportunity to read and write about the exciting world of psychedelic research.

She is currently a postdoctoral fellow at the University of British Columbia (UBC), Canada. She previously completed her PhD in Neuroscience at UBC and her MSc in Pharmacology and Toxicology at the University of Toronto. Her research investigates the neurobiological mechanisms of action of new therapies for neuropsychiatric disorders. Lily is particularly interested in the role of neuroplasticity, the brain’s ability to change through growth and reorganization, in the therapeutic action of breakthrough therapies for depression and related disorders, including ketamine and psychedelics. She’s also a freelance science writer, which helps her stay curious and infuse storytelling into the scientific process.

Lily is hoping to keep learning, make emerging research more accessible, and contribute to an evidence-based discussion around the science and future of psychedelics. She spends her free time trying to keep up with her dog, exploring British Columbia, and going mushroom hunting.

Articles by Lily Aleksandrova, MSc, PhD